Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 PsychemedicsMiragen TherapeuticsPotNetworkBioceptAvant Diagnostics
SymbolNASDAQ:PMDNASDAQ:MGENOTCMKTS:POTNNASDAQ:BIOCOTCMKTS:AVDX
Price Information
Current Price$5.71$0.40$0.01$0.28$0.03
52 Week RangeN/ABuyN/ABuyN/A
Analyst Ratings
Consensus RecommendationN/ABuyN/ABuyN/A
Consensus Price TargetN/A$5.50N/A$1.00N/A
% Upside from Price TargetN/A1,265.10% upsideN/A251.86% upsideN/A
Trade Information
Market Cap$30.07 million$20.81 million$8.37 million$30.66 million$10.78 million
Beta11.863.650.089.42
Average Volume31,287850,5682,642,49512,012,8494,936
Sales & Book Value
Annual Revenue$37.68 million$4.46 millionN/A$5.53 million$250,000.00
Price / Sales0.844.80N/A5.5943.13
Cashflow$1.01 per shareN/AN/AN/AN/A
Price / Cash5.63N/AN/AN/AN/A
Book Value$3.05 per share$0.45 per shareN/A$0.24 per share$0.01 per share
Price / Book1.870.90N/A1.183.20
Profitability
Net Income$1.54 million$-41,870,000.00N/A$-25,140,000.00$-2,370,000.00
EPSN/A($1.34)N/AN/AN/A
Trailing P/E Ratio20.39N/A0.00N/A0.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins4.09%-938.65%N/A-455.14%N/A
Return on Equity (ROE)13.50%-147.81%N/A-218.69%-143.01%
Return on Assets (ROA)9.24%-96.92%N/A-135.91%-51.41%
Dividend
Annual Payout$0.72N/AN/AN/AN/A
Dividend Yield12.61%N/AN/AN/AN/A
Three-Year Dividend Growth6.27%N/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend Growth2 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.12%0.27%N/A0.09%N/A
Current Ratio2.20%2.92%N/A2.50%0.02%
Quick Ratio2.20%2.92%N/A2.36%0.02%
Ownership Information
Institutional Ownership Percentage47.90%28.21%0.01%1.11%0.03%
Insider Ownership Percentage11.20%5.30%4.20%0.32%38.01%
Miscellaneous
Employees2507713952
Shares Outstanding5.52 million53.08 million727.84 million108.71 million336.96 million
Next Earnings Date4/28/2020 (Estimated)5/13/2020 (Estimated)N/A5/13/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel